# FDA Inspection 1222838 - Versiti Indiana Inc. - October 18, 2023

Source: https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/6f1ef91e-3777-466a-8594-0d494e3c2855
Source feed: FDA_Inspections

> FDA Inspection 1222838 for Versiti Indiana Inc. on October 18, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1222838
- Company Name: Versiti Indiana Inc.
- Inspection Date: 2023-10-18
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1180964 - 2022-09-26](https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/8e448043-b6a4-456b-8181-259c5b9e4ba2)
- [FDA Inspection 1180964 - 2022-09-26](https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/68081c6c-2cf4-44ce-a990-95da44942595)
- [FDA Inspection 1115630 - 2020-01-15](https://www.keypedia.com/records/fda_inspections/versiti-indiana-inc/b24f26b7-05f5-4337-881b-61f4d3c6a42a)

Company: https://www.keypedia.com/companies/versiti-indiana-inc/b265a8ec-ed8e-409a-a614-c9ce343b6ce3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d